{"id":"https://openalex.org/W2598147270","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.3072","title":"Safety, immunogenicity, and clinical activity of the immunotherapeutic vaccine, DPX-Survivac, in a Phase 1/1b trial of women with ovarian, fallopian tube, or peritoneal cancer.","display_name":"Safety, immunogenicity, and clinical activity of the immunotherapeutic vaccine, DPX-Survivac, in a Phase 1/1b trial of women with ovarian, fallopian tube, or peritoneal cancer.","publication_year":2015,"publication_date":"2015-05-20","ids":{"openalex":"https://openalex.org/W2598147270","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.3072","mag":"2598147270"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2015.33.15_suppl.3072","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.3072","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2015.33.15_suppl.3072","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012560341","display_name":"Jeannine Villella","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289739345","display_name":"Winthrop-University Hospital","ror":"https://ror.org/03eksqx74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289739345"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeannine A. Villella","raw_affiliation_strings":["Winthrop-University Hospital, Mineola, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Winthrop-University Hospital, Mineola, NY","institution_ids":["https://openalex.org/I1289739345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022328695","display_name":"Michelle K. Wilson","orcid":"https://orcid.org/0000-0002-9106-2607","observed_orcids":["https://orcid.org/0000-0002-9106-2607"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Michelle K. Wilson","raw_affiliation_strings":["Princess Margaret Cancer Centre, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Princess Margaret Cancer Centre, Toronto, ON, Canada","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056927977","display_name":"Neil Lorne Berinstein","orcid":"https://orcid.org/0000-0001-7251-4252","observed_orcids":["https://orcid.org/0000-0001-7251-4252"]},"institutions":[{"id":"https://openalex.org/I112260969","display_name":"Ontario Institute for Cancer Research","ror":"https://ror.org/043q8yx54","country_code":"CA","type":"nonprofit","lineage":["https://openalex.org/I112260969"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Neil Lorne Berinstein","raw_affiliation_strings":["OICR, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OICR, Toronto, ON, Canada","institution_ids":["https://openalex.org/I112260969"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003086828","display_name":"Jennifer G. Brown","orcid":"https://orcid.org/0000-0001-7149-1546","observed_orcids":["https://orcid.org/0000-0001-7149-1546"]},"institutions":[{"id":"https://openalex.org/I1289739345","display_name":"Winthrop-University Hospital","ror":"https://ror.org/03eksqx74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289739345"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Brown","raw_affiliation_strings":["Winthrop-University Hospital, Mineola, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Winthrop-University Hospital, Mineola, NY","institution_ids":["https://openalex.org/I1289739345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031076350","display_name":"St\u00e9phanie Lheureux","orcid":"https://orcid.org/0000-0003-4405-5890","observed_orcids":["https://orcid.org/0000-0003-4405-5890"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Stephanie Lheureux","raw_affiliation_strings":["Princess Margaret Cancer Centre, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Princess Margaret Cancer Centre, Toronto, ON, Canada","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008158683","display_name":"Marcus Otho Butler","orcid":"https://orcid.org/0000-0002-9840-7057","observed_orcids":["https://orcid.org/0000-0002-9840-7057"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Marcus O. Butler","raw_affiliation_strings":["Princess Margaret Cancer Centre, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Princess Margaret Cancer Centre, Toronto, ON, Canada","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090755083","display_name":"Janelle Ramsahai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Janelle Ramsahai","raw_affiliation_strings":["Princess Margaret Cancer Centre, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Princess Margaret Cancer Centre, Toronto, ON, Canada","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009400324","display_name":"Kunle O. Odunsi","orcid":"https://orcid.org/0000-0002-4444-7651","observed_orcids":["https://orcid.org/0000-0002-4444-7651"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kunle Odunsi","raw_affiliation_strings":["Roswell Park Cancer Institute, Buffalo, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roswell Park Cancer Institute, Buffalo, NY","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087132187","display_name":"Mohan Karkada","orcid":"https://orcid.org/0000-0001-7089-9961","observed_orcids":["https://orcid.org/0000-0001-7089-9961"]},"institutions":[{"id":"https://openalex.org/I4210145571","display_name":"Immunovaccine (Canada)","ror":"https://ror.org/05c2mc090","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210145571"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Mohan Karkada","raw_affiliation_strings":["Immunovaccine, Inc., Halifax, NS, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunovaccine, Inc., Halifax, NS, Canada","institution_ids":["https://openalex.org/I4210145571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055054082","display_name":"John J. Nemunaitis","orcid":"https://orcid.org/0000-0002-2234-2381","observed_orcids":["https://orcid.org/0000-0002-2234-2381"]},"institutions":[{"id":"https://openalex.org/I4210087725","display_name":"Mary Crowley Cancer Research Center","ror":"https://ror.org/002ksg449","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210087725"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John J. Nemunaitis","raw_affiliation_strings":["Mary Crowley Cancer Research Centers, Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mary Crowley Cancer Research Centers, Dallas, TX","institution_ids":["https://openalex.org/I4210087725"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074731037","display_name":"Michael Andrew Morse","orcid":"https://orcid.org/0000-0002-5725-4533","observed_orcids":["https://orcid.org/0000-0002-5725-4533"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Morse","raw_affiliation_strings":["Duke University Medical Center, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University Medical Center, Durham, NC","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069625939","display_name":"Tanja B. Pejovic","orcid":"https://orcid.org/0000-0001-8537-1086","observed_orcids":["https://orcid.org/0000-0001-8537-1086"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tanja Pejovic","raw_affiliation_strings":["Oregon Health and Sci Univ, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oregon Health and Sci Univ, Portland, OR","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"middle","author":{"id":null,"display_name":"James Bentley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800264117","display_name":"Queen Elizabeth II Health Sciences Centre","ror":"https://ror.org/025qrzc85","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2800264117","https://openalex.org/I2802394193"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"James Bentley","raw_affiliation_strings":["QEII Health Sciences Center, Halifax, NS, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"QEII Health Sciences Center, Halifax, NS, Canada","institution_ids":["https://openalex.org/I2800264117"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016393893","display_name":"Genevieve M. Weir","orcid":"https://orcid.org/0000-0002-6285-7187","observed_orcids":["https://orcid.org/0000-0002-6285-7187"]},"institutions":[{"id":"https://openalex.org/I4210145571","display_name":"Immunovaccine (Canada)","ror":"https://ror.org/05c2mc090","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210145571"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Genevieve Weir","raw_affiliation_strings":["Immunovaccine Inc, Halifax, NS, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunovaccine Inc, Halifax, NS, Canada","institution_ids":["https://openalex.org/I4210145571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062800449","display_name":"Lisa Diana MacDonald","orcid":"https://orcid.org/0000-0003-4024-8214","observed_orcids":["https://orcid.org/0000-0003-4024-8214"]},"institutions":[{"id":"https://openalex.org/I4210145571","display_name":"Immunovaccine (Canada)","ror":"https://ror.org/05c2mc090","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210145571"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Lisa MacDonald","raw_affiliation_strings":["Immunovaccine, Inc., Halifax, NS, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunovaccine, Inc., Halifax, NS, Canada","institution_ids":["https://openalex.org/I4210145571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088104084","display_name":"Marianne M. Stanford","orcid":"https://orcid.org/0000-0003-0432-3707","observed_orcids":["https://orcid.org/0000-0003-0432-3707"]},"institutions":[{"id":"https://openalex.org/I4210145571","display_name":"Immunovaccine (Canada)","ror":"https://ror.org/05c2mc090","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210145571"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Marianne Stanford","raw_affiliation_strings":["Immunovaccine, Inc., Halifax, NS, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunovaccine, Inc., Halifax, NS, Canada","institution_ids":["https://openalex.org/I4210145571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066953797","display_name":"Tomasz Burzykowski","orcid":"https://orcid.org/0000-0003-3378-975X","observed_orcids":["https://orcid.org/0000-0003-3378-975X"]},"institutions":[{"id":"https://openalex.org/I4210101853","display_name":"International Drug Development Institute (Belgium)","ror":"https://ror.org/016dg3e07","country_code":"BE","type":"company","lineage":["https://openalex.org/I4210101853"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Tomasz Burzykowski","raw_affiliation_strings":["International Drug Development Institute, Louvain la Neuve, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"International Drug Development Institute, Louvain la Neuve, Belgium","institution_ids":["https://openalex.org/I4210101853"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059544295","display_name":"Rita Nigam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210145571","display_name":"Immunovaccine (Canada)","ror":"https://ror.org/05c2mc090","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210145571"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Rita Nigam","raw_affiliation_strings":["Immunovaccine, Inc., Halifax, NS, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunovaccine, Inc., Halifax, NS, Canada","institution_ids":["https://openalex.org/I4210145571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111413324","display_name":"Marc Mansour","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210145571","display_name":"Immunovaccine (Canada)","ror":"https://ror.org/05c2mc090","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210145571"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Marc Mansour","raw_affiliation_strings":["Immunovaccine, Inc., Halifax, NS, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunovaccine, Inc., Halifax, NS, Canada","institution_ids":["https://openalex.org/I4210145571"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072712459","display_name":"Amit M. Oza","orcid":"https://orcid.org/0000-0002-9510-8641","observed_orcids":["https://orcid.org/0000-0002-9510-8641"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Amit M. Oza","raw_affiliation_strings":["Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada","institution_ids":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":11,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"33","issue":"15_suppl","first_page":"3072","last_page":"3072"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.6259999871253967,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.6259999871253967,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.3659999966621399,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/survivin","display_name":"survivin","score":0.628000020980835},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.7149999737739563},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.652999997138977},{"id":"https://openalex.org/keywords/fallopian-tube-cancer","display_name":"fallopian tube cancer","score":0.9779999852180481},{"id":"https://openalex.org/keywords/peritoneal-cancer","display_name":"peritoneal cancer","score":0.9869999885559082},{"id":"https://openalex.org/keywords/metronomic-cyclophosphamide","display_name":"metronomic cyclophosphamide","score":0.8489999771118164},{"id":"https://openalex.org/keywords/vaccine-safety","display_name":"vaccine safety","score":0.6499999761581421},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.753000020980835},{"id":"https://openalex.org/keywords/skin-ulcers","display_name":"skin ulcers","score":0.5789999961853027},{"id":"https://openalex.org/keywords/vaccine-immunogenicity","display_name":"vaccine immunogenicity","score":0.6669999957084656},{"id":"https://openalex.org/keywords/cytotoxic-t-lymphocytes","display_name":"cytotoxic T lymphocytes","score":0.7250000238418579},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.7760000228881836},{"id":"https://openalex.org/keywords/myeloid-derived-suppressor-cells","display_name":"myeloid-derived suppressor cells","score":0.9559999704360962}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8839597702026367},{"id":"https://openalex.org/C2779053233","wikidata":"https://www.wikidata.org/wiki/Q731235","display_name":"ELISPOT","level":4,"score":0.6498525142669678},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6141723394393921},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.5405693054199219},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4887242317199707},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.47500741481781006},{"id":"https://openalex.org/C2775975398","wikidata":"https://www.wikidata.org/wiki/Q906904","display_name":"Survivin","level":3,"score":0.46865835785865784},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.45712560415267944},{"id":"https://openalex.org/C2777249960","wikidata":"https://www.wikidata.org/wiki/Q4818922","display_name":"Fallopian tube cancer","level":4,"score":0.45589780807495117},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3897404670715332},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.34807467460632324},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3361641764640808},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3336026668548584}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2015.33.15_suppl.3072","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.3072","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2015.33.15_suppl.3072","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2597038088","https://openalex.org/W2891861352","https://openalex.org/W2601316275","https://openalex.org/W2024039874","https://openalex.org/W2340925103","https://openalex.org/W3004954919","https://openalex.org/W3031808255","https://openalex.org/W1602732985","https://openalex.org/W2890998636","https://openalex.org/W2890207146"],"abstract_inverted_index":{"3072":[0],"Background:":[1],"Survivin":[2],"is":[3,250,267],"important":[4],"in":[5,53,62,112,150,160,204,222,233,281,288],"apoptosis,":[6],"proliferation,":[7],"and":[8,17,47,84,101,115,123,174,196,228,241,256,274,284,291],"angiogenesis.":[9],"High":[10],"expression":[11],"has":[12],"been":[13],"linked":[14],"to":[15,33,189,243,317],"progression":[16,77],"drug":[18],"resistance.":[19],"DPX-Survivac":[20,249],"vaccine":[21,102],"(DPX)":[22],"contains":[23],"a":[24,35,191,208,244],"mix":[25],"of":[26,51,75,176,259],"survivin":[27],"HLA":[28,130,223],"class":[29],"I":[30,332],"peptides":[31],"designed":[32],"evoke":[34],"cytotoxic":[36],"T":[37,97,104,215],"cell":[38,105,216],"response":[39,49,118,164,212,230],"against":[40],"survivin.":[41],"This":[42],"trial":[43,296],"reports":[44],"the":[45,133,141],"safety":[46],"immune":[48,211,217,246,275],"profiles":[50],"DPX":[52,305,307],"combination":[54],"with":[55,72,132,144,166,193,207,236,253],"metronomic":[56],"low":[57],"dose":[58,85,167,192,266],"oral":[59],"cyclophosphamide":[60],"(CPA)":[61],"ovarian":[63],"cancer":[64],"(OC).":[65],"Methods:":[66],"40":[67],"Stage":[68],"IIc-IV":[69],"OC":[70,283,292],"patients":[71],"no":[73],"evidence":[74,258],"disease":[76,238],"post-platinum":[78,239],"chemotherapy":[79],"were":[80,89,140,187,201,219],"enrolled.":[81],"Adverse":[82],"events":[83],"limiting":[86],"toxicities":[87],"(DLT)":[88],"defined":[90],"by":[91,121],"CTCAE":[92],"v4.03.":[93],"Immune":[94,163,313],"correlates":[95],"(MDSCs;":[96],"regs;":[98],"B":[99,345],"cells)":[100],"induced":[103],"immunity":[106],"(ELISpot;":[107],"tetramer":[108],"analysis)":[109],"was":[110,119,158,231],"assessed":[111,120],"purified":[113],"PBMC":[114,321],"blood.":[116],"Clinical":[117,295],"CT":[122],"CA125.":[124],"Results:":[125],"34/40":[126],"pts":[127],"had":[128],"an":[129],"match":[131],"vaccine.":[134],"Local":[135],"injection":[136],"site":[137],"reactions":[138],"(ISR)":[139],"main":[142],"DLT":[143,157],"2":[145,265,280,341,365,376,380,386,390],"grade":[146,155],"3":[147,156,337,338,343,349,350,353,355,361,362,367,377,382,391,394,398,402],"skin":[148],"ulcerations":[149,200],"cohort":[151,161],"C.":[152],"One":[153],"hematological":[154],"seen":[159,203,221],"2.":[162],"increased":[165],"(B":[168],"vs":[169,179],"C":[170,180,357],"p":[171,181],"=":[172,182],"0.01)":[173],"use":[175],"CPA":[177,303],"(A":[178],"0.02).":[183],"Subsequent":[184],"cohorts":[185],"(Table)":[186],"de-escalated":[188],"find":[190],"similar":[194],"immunogenicity":[195,255],"reduced":[197],"ISR.":[198],"Skin":[199,309],"not":[202],"Cohort":[205,300],"3,":[206],"slightly":[209],"lower":[210],"(non-significant).":[213],"CD4":[214],"responses":[218],"also":[220],"unmatched":[224],"pts.":[225],"A":[226,277,333],"radiological":[227],"biochemical":[229],"confirmed":[232],"1":[234,372],"pt":[235],"residual":[237],"therapy":[240],"correlated":[242],"robust":[245],"response.":[247,276],"Conclusions:":[248],"well":[251],"tolerated":[252],"proven":[254],"preliminary":[257],"clinical":[260],"activity.":[261],"The":[262],"recommended":[263],"phase":[264,279],"based":[268],"on":[269],"tolerance":[270],"for":[271],"localized":[272],"ISR":[273],"randomized":[278],"consolidation/maintenance":[282],"open":[285],"label":[286],"studies":[287],"recurrent":[289],"DLBCL":[290],"are":[293],"planned.":[294],"information:":[297],"NCT01416038.":[298],"Ph":[299],"Pts":[301],"(n)":[302,312],"Priming":[304],"Boost":[306],"(0.1mL)":[308],"ulceration":[310],"Grade":[311],"ELISpot":[314],"Response":[315],"256":[316],">":[318],"4000":[319],"SFU/106":[320],"n":[322,326,329],"(%)":[323],"Dose":[324],"(ml)":[325],"Freq":[327,330],"wks":[328,331],"7":[334],"N":[335],"0.5":[336,360],"0":[339,340,351,352,363,364,404,405,406],"(1)":[342,354,383,395],"(43)":[344],"6":[346,358,373,384,399],"Y":[347,359,374,388,400],"0.1":[348],"(50)":[356],"(1),":[366],"(2)":[368],"5":[369],"(83)":[370],"Ib":[371],"0.25":[375,389,401],"4":[378,392,396,407],"8":[379,393,403],"(2),":[381],"(100)":[385],"9":[387],"(44)":[397],"(67)":[408]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-22T18:32:59.640997","created_date":"2017-04-07T00:00:00"}